Table 2.

Comparison of SALT score, photographic scores and visual analog scale findings among three groups within the time

Treatment group	Prior to treatment	Within 3 months	Within 6 months	Within 9 months	P -value (within groups)
Disease SALT score a
Beamethasone	100% (100-100)	79.50% (68.83-89.25)	63% (40.75-75.16)	74% (64.16-88.41)	<0.001
Methotrexate	100% (100-100)	90.83% (81.16-100)	78% (68.33-100)	77.66% (72-100)	<0.001
Betamethasone+Methotrexate	100% (100-100)	79.50% (63.83-89)	61.83% (24.41-61.83)	57% (37.33-77.66)	<0.001
P-value (between groups)	-	0.044	0.059	0.078
Photographic scores b
Beamethasone	0 (0-0)	1 (0.5-1)	1 (1-2)	1 (0.5-1.25)	<0.001
Methotrexate	0 (0-0)	0.5 (0-1)	1 (0-1)	1 (0-1)	<0.001
Betamethasone+Methotrexate	0 (0-0)	1 (0.5-1)	2 (1-2.5)	2 (1-2)	<0.001
P-value (between groups)	-	0.11	0.073	0.12
Visual analog scale (0-10)
Beamethasone	0 (0-0)	3 (3-4)	5 (4.25-7)	3 (1.25-4)	<0.001
Methotrexate	0 (0-0)	2.5 (0-3)	4 (0-5)	4 (0-5)	<0.001
Betamethasone+Methotrexate	0 (0-0)	3.75 (0.75-5)	6 (3.25-8)	6 (4.25-7)	<0.001
P-value (between groups)	-	0.15	0.14	0.007

^aDecrease in SALT score reflects improvement in the disease.

^bIncrease in photographic score reflects improvement in the disease.